NCT00083135View on ClinicalTrials.gov

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

February 28, 2006

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

filgrastim

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

iobenguane I 131

Trial Locations (7)

19104

Children's Hospital of Philadelphia, Philadelphia

94143

UCSF Comprehensive Cancer Center, San Francisco

90027-0700

Children's Hospital Los Angeles, Los Angeles

46202-5289

Indiana University Cancer Center, Indianapolis

02115

Children's Hospital Boston, Boston

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Hospital Los Angeles

OTHER

NCT00083135 - N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation | Biotech Hunter | Biotech Hunter